Clinical trial Recruiting at 1 site Observational Ages 50 to 75

Observing brain blood vessel health in a community

Official title: PRospective Observation on CErebral microvaScular Structure and Function (PROCESS): a Population-based Prospective Cohort Study

Run by Beijing Tiantan Hospital · NCT06579677 · Data updated 2026-11-12

This study looks at how blood vessel health in the brain is affected by conditions like high blood pressure and diabetes in adults aged 50-75 living in Beijing.

More Cardiovascular Diseases trials

Quick facts

Study typeObservational
Ages50 Years to 75 Years
SexAll
Enrollment3500 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedOctober 18, 2024
Main results expectedMarch 2032
Study endsOctober 2032
Registry record updatedJanuary 6, 2025
Trial IDNCT06579677 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 50-75 years living in Beijing.

Probably not a fit

Patients with serious neurological disorders or significant disabilities will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prevalence and characteristics of cerebral small vessel dysfunction in a community population in Beijing, China, using advanced vascular imaging techniques. It will investigate how vascular risk factors, such as hypertension and diabetes, affect cerebral small vessel dysfunction and its relationship with cognitive and cerebrovascular health. The study will involve community-dwelling adults aged 50-75 years and will not include any interventions, focusing instead on observational data collection. The findings could provide insights into the early pathologic changes associated with major brain diseases.

Why it matters

Potential benefit: If successful, this study could enhance understanding of brain health and lead to better prevention strategies for major brain diseases.

How similar studies have gone: While studies on cerebral small vessel dysfunction exist, this specific population-based approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Community-dwelling adults aged 50-75 years;
2. Registered Beijing household residents or residents who can be followed up stably in their own communities for a long period;
3. Subjects with written informed consents.

Exclusion Criteria:

1. Residents with moderate to severe disabilities (MRS ≥3), mental illness, stroke, dementia, and other serious neurological disorders (e.g., encephalitis, Parkinson's disease, epilepsy, brain tumors, and rare genetic diseases of the nervous system);
2. Life expectancy of ≤4 years due to serious diseases such as end-stage cancer;
3. Contraindications to magnetic resonance imaging such as implanted devices (e.g., pacemakers, defibrillators, and others);
4. Residents who are participating in other studies.

Where it's running

  • Beijing Daxing District People Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting

Study contacts

  • Principal investigator: Yilong Wang, MD, PhD — Beijing Tiantan Hospital
  • Study coordinator: Yuesong Pan, PhD
  • Email: panys2000@163.com
  • Phone: 010-59975807

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.